Therapeutic drug monitoring of letermovir in allogeneic haematopoietic stem cell transplant (allo-HSCT) recipients: a prospective, two-centre observational study (ESCMID Global 2026) - Feb 4, 2026 - Abstract #O0100; Pres time: Apr 18, 2026; 11:36 AM - 11:48 AM; Location: Hall A2-2; No abstract available
Clinical • Observational data • Bone Marrow Transplantation • Transplantation
|
|
J.S. Tang; T.Y. Pai; Y.W. Wang; C.Y. Chen; H.A. Hou; B.S. Ko; P.Y. Chen; Y.J. Liu; H.Y. Lin; Y.H. Wu; Y.J. Chen; S.W. Lin
|